RxDoctor Payments Data

Robert Stillwell

Acute Care · Greenville, NCNPI 1770068397

Payments from drug & device makers

$363in general payments, 2019–2025

Across 22 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$172
  • UCB, Inc.$87
  • Chiesi USA, Inc.$28
  • Teleflex LLC$24
  • Haemonetics Corporation$19
  • Bayer$19
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$363100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)10$172
UCB, Inc.5$87
Chiesi USA, Inc.2$28
Teleflex LLC2$24
Haemonetics Corporation1$19
Bayer1$19
CSL Behring1$13

How this compares

$363 in reported general payments places this provider in the 60th percentile of 312 acute care providers in North Carolina.

See all acute care providers in North Carolina

Medicare billing

Part B allowed, 2024
$7,301
Medicare patients
37
Services billed
77

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →